Patient

Stuart Therapeutics has announced the first patient first visit for its phase 3 clinical trial of ST-100 ophthalmic solution for patients with dry eye disease.

PHILADELPHIA — The efficacy of patient navigators may not improve the self-rated health of children with chronic kidney disease; however, caregivers gain skills from the program, according to research presented at ASN Kidney Week.

WASHINGTON — In this video from the Digital Therapeutics Alliance Summit, Amy Edgar, APRN, CRNP, FNP-C, discusses the need to design digital therapeutics with the patient and provider in mind.

WASHINGTON — Digital health technologies must have value, and must meet certain requirements for improved patient care, according to a panel discussion at the Digital Therapeutics Alliance Summit.

As the patient-to-medical staff ratio narrows partially due to demand for medical services and current staffing shortages, clinicians are looking for new ways to assess conditions and develop treatment options.

NEW ORLEANS — Nerf guns can cause ocular damage, contributing to the burden on health care and patient resources, according to a poster presentation at the Association for Research in Vision and Ophthalmology meeting.

More than 5 million patient charts have been entered into the Acumen Epic Connect platform, according to press release.

Patient withdrawal from cancer clinical trials can result in systematic bias, insufficiently powered studies and a loss of valuable scientific knowledge, according to a study in JAMA Network Open.

Quality of life with glaucoma can be affected not only by vision loss, but also by less tangible factors such as the burden of daily drops or an increase in fear and anxiety.

The first patient has been enrolled in a phase 2 clinical study evaluating YP-P10 for the treatment of dry eye disease, according to a press release from Yuyu Pharma.